2018

Cardiac Dimensions News Page

Cardiac Dimensions Takes on Abbott and Edwards in FMR Market

Cardiac Dimensions has raised $39 million to build strong clinical evidence for its Carillon Mitral…

Arboretum_JDApril 30, 2018

Cardiac Dimensions News Page

Cardiac Dimensions Announces $39 Million Series B Financing for Innovative Device to Treat Patients With Heart Failure

Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatments for patients with…

Arboretum_JDApril 26, 2018

News Page Pear Therapeutics

Pear Therapeutics and Sandoz Announce Deal to Commercialize Prescription Digital Therapeutics

Pear Therapeutics, Inc. today announced a deal with Sandoz, a division of Novartis, to commercialize…

Arboretum_JDApril 19, 2018

News Page Swift Biosciences

Swift Biosciences Launches Accel-Amplicon Plus Cancer Panels for Precision Medicine Initiatives

Swift Biosciences today announced the commercial release of its Accel-Amplicon Plus™ Cancer NGS Panels, a…

Arboretum_JDApril 18, 2018

News Page nVision

Boston Scientific Announces Acquisition Of nVision Medical Corporation

Boston Scientific (NYSE: BSX) today announced that it has acquired nVision Medical Corporation, a privately-held…

Arboretum_JDApril 16, 2018

News Page Pear Therapeutics

Pear Therapeutics President and CEO Corey McCann Receives ISCDD 2018 Innovation Award

The International Society for CNS Drug Development (ISCDD) announced today that Corey McCann, M.D., Ph.D.,…

Arboretum_JDMarch 29, 2018

BioIQ News Page

BioIQ Raises 26.5M to Transform Value-Based Care Delivery for Payers, Providers and Consumers

BioIQ, a healthcare technology company driving the shift to value-based care, announced today it has…

Arboretum_JDMarch 22, 2018

News Page NxThera

Boston Scientific Announces Agreement To Acquire NxThera

Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement to…

Arboretum_JDMarch 21, 2018

News Page Pear Therapeutics

Pear Therapeutics featured in New York Times Article – Take This App and Call Me in the Morning

A new category of prescription medical treatments, what executives call digital therapeutics, comes in the…

Arboretum_JDMarch 19, 2018

News Page NxThera

NxThera Announces MTOPS Trial Data

NxThera, Inc., a medical device company pioneering the application of its Convective Water Vapor Energy…

Arboretum_JDMarch 16, 2018

Cardiac Dimensions Takes on Abbott and Edwards in FMR Market

Cardiac Dimensions Announces $39 Million Series B Financing for Innovative Device to Treat Patients With Heart Failure

Pear Therapeutics and Sandoz Announce Deal to Commercialize Prescription Digital Therapeutics

Swift Biosciences Launches Accel-Amplicon Plus Cancer Panels for Precision Medicine Initiatives

Boston Scientific Announces Acquisition Of nVision Medical Corporation

Pear Therapeutics President and CEO Corey McCann Receives ISCDD 2018 Innovation Award

BioIQ Raises 26.5M to Transform Value-Based Care Delivery for Payers, Providers and Consumers

Boston Scientific Announces Agreement To Acquire NxThera

Pear Therapeutics featured in New York Times Article – Take This App and Call Me in the Morning

NxThera Announces MTOPS Trial Data

News & Insights

ARCHIVES